Clinical Trial Site

Germantown, Tennessee 38138

0 studies enrolling now · 3 studies all time

What they study most

Hereditary Transthyretin-mediated (ATTRv) Amyloidosis, High Cardiovascular Risk, Hypertension, Iron Deficiency Anemia, Polyneuropathy

Studies at this site

• Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3) — Completed
• A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA) — Completed
• A Multicenter Observational Study to Evaluate the Effectiveness of Patisiran in Patients With Polyneuropathy of ATTRv Amyloidosis With a V122I or T60A Mutation — Completed